Commentary Open Access
Volume 1 | Issue 1 | DOI: https://doi.org/10.46439/Psychiatry.1.001
Can language use in social media help in the treatment of severe mental illness?
Deanna L. Kelly1,*, Max Spaderna1, Vedrana Hodzic1, Glen Coppersmith2, Shuo Chen1, Philip Resnik3
- 1University of Maryland Baltimore, School of Medicine, Baltimore, MD, USA
- 2Qntfy Corporation, Arlington, VA, USA
- 3University of Maryland College Park, Department of Linguistics and Institute for Advanced Computer Studies, College Park, MD, USA
Corresponding Author
Deanna L. Kelly, dlkelly@som.umaryland.edu
Received Date: January 13, 2021
Accepted Date: January 29, 2024
Kelly DL, Spaderna M, Hodzic V, Coppersmith G, Chen S, Resnik P. Can language use in social media help in the treatment of severe mental illness? Curr Res Psychiatry. 2021; 1(1):1-4.
Copyright: © 2021 Kelly DL, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Articles
Nemo-like kinase as a potential target for treatment of Diamond Blackfan Anemia
Diamond Blackfan Anemia (DBA) is a congenital bone marrow failure syndrome characterized by hypoproliferative anemia, in which the major defect is ineffective erythropoiesis. Over 70% of patients with DBA have mutations in ribosomal protein subunits, although the precise molecular mechanisms contributing to the pathogenesis of DBA are not well understood.
The significance of triple-capsid-mutant AAV8 for treatment of Sanfilippo Syndrome Type B
Sanfilippo Syndrome Type-B remains an untreatable childhood neurodegenerative disease with great burden for both patient and caregiver. Very few clinical trials have been undertaken to treat the disease, and none of these have yet yielded clinically obtainable products for patients. Caused by a simple enzyme function deficiency, Sanfilippo Syndrome Type-B has been considered a great prospect for gene-therapy interventions.
Drought treatment: A new tool for dissecting XA21 signaling in rice
Microbial infection can cause cell damage in both plants and animals, as well as triggering stress responses commonly induced by environmental (abiotic) cues.
Ocular cystinosis – A review of disease, diagnosis, and future treatment options
Cystinosis is a rare autosomal recessive lysosomal storage disorder, characterised by the intra-lysosomal accumulation of cystine. Cystinosis results from a defect in the CTNS protein, a lysosomal transport protein for cystine. There are three subtypes of cystinosis: infantile nephropathic cystinosis, juvenile nephropathic cystinosis and ocular non-nephropathic cystinosis.
Bevacizumab (Avastin) in treatment of maculopathy secondary to proliferative diabetic retinopathy (PDR) in Afghanistan
This is a clinical study which assessed the safety and efficacy of Bevacizumab (Avastin), manufactured by Genentech, in the treatment of maculopathy secondary to Proliferative Diabetic Retinopathy (PDR). All of the patients suffered from Type II Diabetes Mellitus.
A total of 174 (97 male, 77 female) patients (308 study eyes in total) took part in the clinical study with an average age of 57 years (range 27-80 years). 56 patients (32%) in the study were insulin dependent diabetics. Bevacizumab was given to patients by monthly intra-vitreal injections at a dose of 50 µL per treatment. The Visual Acuity (VA) was assessed using the Snellen technique before and after the Bevacizumab injection and with Optical Coherence Tomography (OCT).